InVivo Therapeutics Holdings Corp. Elects Robert J. Rosenthal as a Director
November 12, 2019 at 07:47 am
On November 8, 2019, the Board of Directors of InVivo Therapeutics Holdings Corp. elected Robert J. Rosenthal, Ph.D. as a director, effective immediately. Dr. Rosenthal will serve as a Class III director with a term expiring at the Company's 2020 annual meeting of the stockholders of the Company and until such time as his successor is duly elected and qualified, or until his earlier death, resignation or removal. The Board expects to appoint Dr. Rosenthal to one or more committees of the Board at a later date. The Company will file an amendment to this Current Report on Form 8-K to report any such appointment within four business days after the information is determined or becomes available. Dr. Rosenthal currently serves as Chairman of the Board of Taconic Biosciences Inc.